Dexmedetomidine
- Empirical Formula: C13H16N2
- Molecular Weight: 0
- MDL number: MFCD00880557
- Update Date: 2023-04-23 13:52:06
What is Dexmedetomidine?
Description
Dexmedetomidine has an eight times increased affinity for the α2-receptor compared with clonidine and therefore produces less cardiovascular instability at comparable doses.
The Uses of Dexmedetomidine
Dexmedetomidine is principally used as a sedative in mechanically ventilated patients in ICU. I t is particularly useful in those patients with delirium.
The Uses of Dexmedetomidine
Dexmedetomidine is the S -enantiomer of the veterinary anaesthetic medetomidine. It has highly selective activity at α2 adrenoceptors (1600 : 1 α2 : α1) and eight times more affinity than clonidine for this site. D exmedetomidine is licenced in the UK for i.v. sedation of adult patients in intensive care, although there is off-licence use, such as for procedural sedation during an awake craniotomy.
brand name
Precedex (Hospira).
Mechanism of action
Dexmedetomidine is metabolised via hepatic glucuronidation, and clearance is reduced in patients with liver impairment. Very li??le unchanged drug reaches the urine, but 95% of degradation products are excreted this way (4% in faeces). There is a theoretical possibility of accumulation of metabolites in patients with renal failure, but toxicity has not been described because active metabolites of dexmedetomidine have not been identified at present.
Pharmacokinetics
Dexmedetomidine is freely soluble in water and has a pKa of 7.1. The pharmaceutical formulation is a clear, colourless preservative-free solution with a pH of 4.5–8. Protein binding of dexmedetomidine is 94%, with negligible displacement by drugs commonly used in anaesthetic and I CU practice. The elimination half-life is approximately 2h and the steady-state volume of distribution is 118 l. There are no significant differences in the pharmacokinetic profile in the elderly, but an enhanced clinical response is seen.
Veterinary Drugs and Treatments
In the USA, dexmedetomidine for dogs is approved for use as a sedative
and analgesic to facilitate clinical examinations, clinical procedures,
minor surgical procedures, and minor dental procedures, and
as a preanesthetic to general anesthesia.
In Europe, dexmedetomidine is additionally indicated for use in
cats similarly to dogs above, but when used as premed it is indicated
for use prior to ketamine general anesthesia.
Properties of Dexmedetomidine
| Melting point: | 144-147°C |
| storage temp. | -20°C Freezer |
| solubility | Chloroform (Slightly), Methanol (Slightly) |
| form | Solid |
| color | White to Off-White |
Safety information for Dexmedetomidine
Computed Descriptors for Dexmedetomidine
New Products
2-(2-Ethoxyphenoxy)ethyl bromide 1,3-Dibromo-2,2-dimethoxypropane 8-Bromo-7-(2-butynyl)-3-methyl xanthine 5-Chlorothiophene-2-carboxylic acid 8-Bromo-3-methyl xanthine Maleic hydrazide o-Anisaldehyde 4-Bromobenzaldehyde 3-Fluorobenzaldehyde 2-Chlorobenzaldehyde 3-Amino-3-(3-fluorophenyl)propanoic acid 1-Propyl-4-piperidone 2,3-Dihydro-5,6-dimethoxy-2-(4-piperidinylmethyl)-1H-inden-1-one hydrochloride 3-(4-Bromo-3-methyl-2-oxo-2,3-dihydro-1h-benzo[d]imidazol-1-yl)piperidine-2,6-dione 2-Fluoro-6-iodobenzoic acid 3-Pyridineacrylic acid 1-Boc-4-cyanopiperidine ethyl 2-oxo-2,3,9,10-tetrahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline-8(7H)-carboxylate Vardenafil Bis-sulphonamide(Dimer) Nitroso Irbesartan N-Nitroso Nortriptyline Sulfonic acid Impurity 2-(p-Tolyl)acetaldehyde 2,2-dibromo-1-cyclopropyl-2-(2-fluorophenyl)ethan-1-oneRelated products of tetrahydrofuran
You may like
-
Deuterated Styrene-d8 19361-62-7 97-99%View Details
19361-62-7 -
1187989-89-4 97-99%View Details
1187989-89-4 -
(S)-2-Bromobutanoic acid 97-99%View Details
32659-49-7 -
665020-24-6 ethyl 1-(2,4-dichlorophenyl)-4,5-dihydro-1H-benzo[g]indazole-3-carboxylate 97-99%View Details
665020-24-6 -
methyl 3-amino-4-formylbenzoate 97-99%View Details
212322-17-3 -
3-bromo-[1,1'-biphenyl]-2-amine 1620885-59-7 97-99%View Details
1620885-59-7 -
(13S,17S)-13-methyl-3-oxo-2,3,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate 2590-41-2 97-99%View Details
2590-41-2 -
1503408-77-2 6-Chloro-3,4-dimethylpyridin-2-amine 97-99%View Details
1503408-77-2



